Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions

Introduction

Post-traumatic stress disorder (PTSD) is a disabling condition characterised by re-experiencing, affect dysregulation, hypervigilance and avoidance linked to traumatic memories. The authors note that standard treatments leave a substantial proportion of patients with persistent symptoms — only about 50-60% no longer meet diagnostic criteria in the most successful trials — and this has renewed interest in alternative approaches. Over the past two decades, MDMA-assisted psychotherapy (MDMA-AP) has been investigated in Phase II trials for severe, treatment-resistant PTSD, producing promising quantitative results but little detailed information about participants’ lived experience during and after treatment. This study aimed to fill that gap by analysing participants’ descriptions of change as recorded in clinical integration sessions following MDMA-AP from a Phase II open‑label trial. Using an Interpretative Phenomenological Analysis (IPA) approach, Godes and colleagues sought to identify perceived mechanisms of change, how therapeutic elements were integrated into daily life, and the phenomenological qualities of recovery reported by patients with severe PTSD. The authors position this work as complementary to quantitative outcome data, offering a finer-grained view of how participants experience processing, symptom relief and longer‑term growth after MDMA-AP.